Your English writing platform
Discover LudwigSuggestions(3)
Exact(9)
All of these data were obtained in developed countries such as Japan and various European countries, and the causes of CHF in these countries differ from the causes of CHF in developing countries.
However, the causes of CHF increases in nanofluids could not be explained using traditional CHF correlations.
Figure 2 depicts the cumulative risk of cardiomyopathy among those patients lacking other discernible causes of CHF (group 3).
The NTHFI-CA is defined for all stages and causes of CHF, for NT resident population who receive care within six domains of treatment.
Further research could examine additional aspects of the effects of exercise training in this population, for example, the impact on the responses to exercise training under different levels of severity and the underlying causes of CHF.
The risk stratification of CHF patients may be different between developed and developing countries because the causes of CHF and the extent of inflammatory activation are not the same.
Similar(51)
A consensus explanation of the cause of CHF enhancement in nanofluids seems to be obtainable via an intense study focused on the effect of the nanoparticle layer.
In clinical practice, diastolic dysfunction is a common entity, especially in patients with hypertension and ischaemic cardiomyopathy, and it is the predominant cause of CHF in 40 50% of patients.
In patients with preserved LV function, the cause of CHF was nonischemic.
Stage C was diagnosed in 50 (60.2%) of the patients, representing the major cause of CHF.
Similarly, lack of cardiac muscle biopsy specimens and details of echocardiograms prevent definitive determination of the presence of cardiomyopathy, as opposed to some other cause of CHF.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com